Mark E. Legaz

1.3k citations

12 papers · 1.2k indexed · h-index 10

Impact in

Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Venomous Animal Envenomation and Studies

Papers in

Hematology 5
- Blood Coagulation and Thrombosis Mechanisms 3
- Hemophilia Treatment and Research 2
- Hemostasis and retained surgical items 1
Genetics 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3

Co-authors: Earl W. Davie Kazuo Fujikawa Richard B. Counts Arthur R. Thompson Gottfried Schmer Hisao Kato Robert G. Meyer Michael H. Coan
Journals: Biochemistry (5 papers)Annals of the New York Academy of Sciences (2 papers)Archives of Biochemistry and Biophysics (1 paper)Clinical Biochemistry (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
Partner nations: United States

In The Last Decade

Mark E. Legaz

12 papers receiving 920 citations

Peers

Countries citing papers authored by Mark E. Legaz

Since Specialization

Citations

This map shows the geographic impact of Mark E. Legaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Legaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Legaz more than expected).

Fields of papers citing papers by Mark E. Legaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Legaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Legaz. The network helps show where Mark E. Legaz may publish in the future.

Co-authors

The 16 scholars most cited alongside Mark E. Legaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Legaz Line = papers co-authored together Mark E. Legaz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Human thrombin: Partial primary structure Archives of Biochemistry and Biophysics ·Arthur R. Thompson, David L. Enfield, Lowell H. Ericsson, Mark E. Legaz, John W. Fenton	1977	51
2	[9] Bovine factor VIII (antihemophilic factor) Methods in enzymology on CD-ROM/Methods in enzymology ·Mark E. Legaz, Earl W. Davie	1976	8
3	Correlation of the “Emit” antiepileptic drug assay with a gas liquid chromatographic method Clinical Biochemistry ·Mark E. Legaz, Vidmantas A. Raisys	1976	22
4	PROPERTIES OF BOVINE FACTOR IX (CHRISTMAS FACTOR)* Annals of the New York Academy of Sciences ·Earl W. Davie, Kazuo Fujikawa, Hisao Kato, Mark E. Legaz	1975	6
5	ISOLATION, SUBUNIT STRUCTURE, AND PROTEOLYTIC MODIFICATION OF BOVINE FACTOR VIII* Annals of the New York Academy of Sciences ·Mark E. Legaz, Mark Weinstein, Charles M. Heldebrant, Earl W. Davie	1975	34
6	Mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways Biochemistry ·Kazuo Fujikawa, Michael H. Coan, Mark E. Legaz, Earl W. Davie	1974	131
7	Mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa(activated plasma thromboplastin antecedent) Biochemistry ·Kazuo Fujikawa, Mark E. Legaz, Hisao Kato, Earl W. Davie	1974	163
8	SEQUENCE DEPENDENT DEAMIDATION RATES FOR MODEL PEPTIDES OF CYTOCHROME C International journal of peptide & protein research ·Arthur B. Robinson, James H. McKerrow, Mark E. Legaz	1974	40
9	Isolation and Characterization of Human Factor VIII (Antihemophilic Factor) Journal of Biological Chemistry ·Mark E. Legaz, Gottfried Schmer, Richard B. Counts, Earl W. Davie	1973	187
10	Isolation and characterization of bovine factor IX (Christmas factor) Biochemistry ·Kazuo Fujikawa, Arthur R. Thompson, Mark E. Legaz, Robert G. Meyer, Earl W. Davie	1973	182
11	Bovine factors X₁and X₂(Stuart factor). Isolation and characterization Biochemistry ·Kazuo Fujikawa, Mark E. Legaz, Earl W. Davie	1972	191
12	Bovine factor X₁ (Stuart factor). Mechanism of activation by a protein from Russell's viper venom Biochemistry ·Kazuo Fujikawa, Mark E. Legaz, Earl W. Davie	1972	158

About Mark E. Legaz

Mark E. Legaz is a scholar working on Hematology, Genetics, Biotechnology, Animal Science and Zoology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Hemophilia Treatment and Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Protein purification and stability (1 paper), Blood properties and coagulation (1 paper), Hemostasis and retained surgical items (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Hematology (780 citations), Genetics (300 citations), Pulmonary and Respiratory Medicine (262 citations), Biotechnology (67 citations) and Cancer Research (110 citations). Mark E. Legaz has collaborated with scholars based in United States. Frequent co-authors include Earl W. Davie, Kazuo Fujikawa, Richard B. Counts, Arthur R. Thompson, Gottfried Schmer, Hisao Kato, Robert G. Meyer, Michael H. Coan, Arthur B. Robinson and James H. McKerrow. Their work appears in journals such as Biochemistry, Annals of the New York Academy of Sciences, Archives of Biochemistry and Biophysics, Clinical Biochemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact